Status: Open
Specialty: Prostate
Date Opened: 05/03/2025
Planned Close Date: 01/11/2025
Sponsor:
Principal Investigator: Professor Alison Birtle
Study Title: RENAISSANCE.
RENAISSANCE - A multi-centre, non-interventional study of RElugolix as aNdrogen-deprivAtion therapy In patientS with advanced hormone-Sensitive prostate cANCEr
The goal of this study is to generate real word evidence from Europe about the population, effectiveness, and persistence of relugolix treatment in patients with advanced hormone-sensitive prostate cancer and their clinical course during treatment.
Research Nurse: Hilary Thatcher
Administrator: research.oncology@mbht.nhs.uk
Link to EDGE